AccuAim

Device Zimmer Biomet Holdings, Inc.
Total Payments
$17,512
Transactions
7
Doctors
6
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2019 $17,175 1 0
2017 $336.98 6 6

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $17,175 1 98.1%
Food and Beverage $336.98 6 1.9%

Payments by Type

Research
$17,175
1 transactions
General
$336.98
6 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
A Randomized Controlled Trial of the Subchondroplasty Procedure with Arthroscopy versus Arthroscopy Alone for Treatment of Bone Marrow Lesions in the Knee Zimmer Biomet Holdings, Inc. $17,175 0

Top Doctors Receiving Payments for AccuAim

Doctor Specialty Location Total Records
Unknown Encinitas, CA $17,175 1
, MD Orthopaedic Surgery Chicago, IL $60.40 1
, M.D Orthopaedic Surgery Reston, VA $60.40 1
, MD Sports Medicine Chevy Chase, MD $60.40 1
, M.D Orthopaedic Surgery Washington, DC $60.40 1
, M.D Orthopaedic Surgery Manassas, VA $47.69 1
, MD Sports Medicine Manassas, VA $47.69 1

About AccuAim

AccuAim is a device associated with $17,512 in payments to 6 healthcare providers, recorded across 7 transactions in the CMS Open Payments database. The primary manufacturer is Zimmer Biomet Holdings, Inc..

Payment data is available from 2017 to 2019. In 2019, $17,175 was paid across 1 transactions to 0 doctors.

The most common payment nature for AccuAim is "Unspecified" ($17,175, 98.1% of total).

AccuAim is associated with 1 research study, including "A Randomized Controlled Trial of the Subchondroplasty Procedure with Arthroscopy versus Arthroscopy Alone for Treatment of Bone Marrow Lesions in the Knee" ($17,175).